Windtree Therapeutics (WINT) Short Interest Ratio & Short Volume $0.56 -0.03 (-5.11%) As of 09:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Windtree Therapeutics Short Interest DataWindtree Therapeutics (WINT) has a short interest of 2.60 million shares. This marks a 1,508.91% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 5.80 million shares to cover all short positions.Current Short Interest2,600,000 sharesPrevious Short Interest161,600 sharesChange Vs. Previous Month+1,508.91%Dollar Volume Sold Short$2.15 millionShort Interest Ratio0.3 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares3,660,000 sharesPercentage of Shares Shorted71.04%Today's Trading Volume174,141 sharesAverage Trading Volume5,795,151 sharesToday's Volume Vs. Average3% Short Selling Windtree Therapeutics? Sign up to receive the latest short interest report for Windtree Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWINT Short Interest Over TimeWINT Days to Cover Over TimeWINT Percentage of Float Shorted Over Time Windtree Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20252,600,000 shares $2.15 million +1,508.9%N/A0.3 $0.83 6/30/2025161,600 shares $83.40 thousand -82.6%4.4%1.2 $0.52 6/15/2025930,100 shares $550.62 thousand +411.0%25.5%0.3 $0.59 5/31/2025182,000 shares $142.52 thousand +70.4%24.3%0 $0.78 5/15/2025106,800 shares $88.64 thousand +110.2%14.3%0 $0.83 4/30/202550,800 shares $59.44 thousand -23.6%6.8%0 $1.17 4/15/202566,500 shares $78.47 thousand -76.2%8.9%0 $1.18 3/31/2025279,300 shares $351.92 thousand +466.5%37.3%0.1 $1.26 3/15/202549,300 shares $101.07 thousand -40.6%6.6%0 $2.05 2/28/202583,000 shares $263.94 thousand +44.9%11.1%0.3 $3.18 Get the Latest News and Ratings for WINT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Windtree Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202557,300 shares $393.65 thousand -67.1%7.7%0.4 $6.87 1/31/2025174,100 shares $22.74 thousand -80.9%1.6%0 $0.13 1/15/2025909,000 shares $220.89 thousand +72.4%8.3%0.3 $0.24 12/31/2024527,200 shares $184.15 thousand +6.1%5.9%0.2 $0.35 12/15/2024497,000 shares $175.64 thousand +228.5%5.6%0.3 $0.35 11/30/2024151,300 shares $80.26 thousand +389.6%1.7%0.1 $0.53 11/15/202430,900 shares $14.68 thousand -84.2%0.4%0 $0.48 10/31/2024195,700 shares $137.66 thousand +301.9%2.4%0.1 $0.70 10/15/202448,700 shares $32.14 thousand -50.7%1.4%0 $0.66 9/30/202498,700 shares $235.89 thousand +174.9%2.8%0.1 $2.39 9/15/202435,900 shares $113.80 thousand -65.9%2.6%0 $3.17 8/31/2024105,400 shares $854.79 thousand -6.8%23.9%0.1 $8.11 8/15/2024113,100 shares $1.26 million -56.8%25.6%0.1 $11.14 7/31/2024261,700 shares $2.39 million +455.6%59.3%0.3 $9.12 7/15/202447,100 shares $174.27 thousand -17.5%10.7%1.5 $3.70 6/30/202457,100 shares $183.29 thousand +21.2%12.9%1.8 $3.21 6/15/202447,100 shares $146.01 thousand +20.8%10.7%1.7 $3.10 5/31/202439,000 shares $138.06 thousand +89.3%9.1%1.6 $3.54 5/15/202420,600 shares $94.78 thousand +62.2%4.8%0.8 $4.60 4/30/202412,700 shares $63.88 thousand +388.5%3.0%0.6 $5.03 4/15/20242,600 shares $19.66 thousand -93.5%N/A0.2 $7.56 3/31/202439,700 shares $14.05 thousand +30.2%0.5%0.2 $0.35 3/15/202430,500 shares $10.37 thousand -47.8%0.4%0.1 $0.34 2/29/202458,400 shares $21.02 thousand -42.2%0.8%0.2 $0.36 2/15/2024101,100 shares $36.09 thousand -56.0%1.9%0.3 $0.36 1/31/2024229,600 shares $96.50 thousand +353.8%5.3%0.8 $0.42 1/15/202450,600 shares $28.95 thousand +25.6%1.0%0.2 $0.57 12/31/202340,300 shares $28.98 thousand +108.8%N/A0.3 $0.72 12/15/202319,300 shares $14.09 thousand -55.5%0.5%0.2 $0.73 11/30/202343,400 shares $50.34 thousand -13.4%1.1%0.4 $1.16Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 11/15/202350,100 shares $46.08 thousand -22.5%1.2%0.5 $0.92 10/31/202364,600 shares $67.83 thousand -65.8%1.5%0.5 $1.05 10/15/2023188,900 shares $236.13 thousand +540.3%4.3%1.5 $1.25 9/30/202329,500 shares $27.98 thousand +81.0%0.7%0.2 $0.95 9/15/202316,300 shares $18.75 thousand +27.3%0.4%0.1 $1.15 8/31/202312,800 shares $14.10 thousand -75.8%2.0%0.1 $1.10 8/15/202352,800 shares $85.54 thousand +294.0%7.9%0.2 $1.62 7/31/202313,400 shares $18.63 thousand +162.8%2.0%0 $1.39 7/15/20235,100 shares $6.83 thousand -42.1%N/A0 $1.34 6/30/20238,800 shares $11 thousand -90.5%N/A0 $1.25 6/15/202392,500 shares $142.45 thousand -2.9%N/A0.1 $1.54 5/31/202395,300 shares $121.98 thousand -51.2%N/A0.1 $1.28 5/15/2023195,100 shares $290.70 thousand +64.4%N/A0.2 $1.49 4/30/2023118,700 shares $194.67 thousand +136.9%68.7%0.1 $1.64 4/15/202350,100 shares $219.44 thousand +87.6%8.5%0.1 $4.38 3/31/202326,700 shares $133.23 thousand -2.9%4.7%0.2 $4.99 3/15/202327,500 shares $132.55 thousand -53.0%4.9%0.3 $4.82 2/28/202358,500 shares $367.38 thousand +604.8%10.3%0.6 $6.28 2/15/20238,300 shares $1.23 thousand -98.9%N/A0.1 $0.15 1/31/2023754,800 shares $120.77 thousand +16.1%N/A1.4 $0.16 1/15/2023650,300 shares $143.03 thousand -28.2%N/A1.3 $0.22 12/30/2022905,900 shares $154.00 thousand -28.7%N/A2 $0.17 12/15/20221,270,000 shares $226.06 thousand +4.1%N/A1.4 $0.18 11/30/20221,220,000 shares $234.85 thousand -3.2%N/A1.3 $0.19 11/15/20221,260,000 shares $110.25 thousand -9.4%5.3%1.2 $0.09 10/31/20221,390,000 shares $238.39 thousand -10.9%7.4%0.7 $0.17 10/15/20221,560,000 shares $379.70 thousand +26.8%8.3%0.8 $0.24 9/30/20221,230,000 shares $369.12 thousand +44.6%6.5%0.7 $0.30 9/15/2022850,900 shares $314.66 thousand -8.3%4.5%0.6 $0.37 8/31/2022928,000 shares $365.63 thousand +21.9%5.1%0.7 $0.39 8/15/2022761,500 shares $288.61 thousand +0.0%4.2%0.6 $0.38 7/31/2022761,200 shares $299.91 thousand -19.9%4.3%3.1 $0.39 7/15/2022950,700 shares $384.56 thousand +6.8%5.4%3.4 $0.40 6/30/2022890,200 shares $371.21 thousand +3.6%5.1%1.1 $0.42 6/15/2022858,900 shares $365.03 thousand -7.5%4.9%1.1 $0.43 5/31/2022928,500 shares $452.18 thousand +18.9%5.4%1.2 $0.49 5/15/2022781,200 shares $429.66 thousand -12.1%4.5%1.1 $0.55 4/30/2022888,700 shares $657.28 thousand +104.6%5.3%1.3 $0.74 4/15/2022434,400 shares $462.68 thousand -0.5%2.6%0.6 $1.07 3/31/2022436,400 shares $497.50 thousand -9.1%2.6%3.9 $1.14 3/15/2022480,100 shares $458.50 thousand +10.4%2.9%3.4 $0.96 2/28/2022434,800 shares $465.24 thousand -21.0%2.6%3.1 $1.07 2/15/2022550,600 shares $578.13 thousand +60.9%3.3%3.4 $1.05 1/31/2022342,200 shares $386.69 thousand -30.6%2.0%1.9 $1.13 1/15/2022493,000 shares $734.57 thousand +3.1%2.9%2.5 $1.49 12/31/2021478,000 shares $769.58 thousand -19.7%2.8%1.8 $1.61 12/15/2021595,400 shares $940.73 thousand -12.9%3.5%1.7 $1.58 11/30/2021683,600 shares $1.17 million -5.3%4.2%2 $1.71 11/15/2021721,900 shares $1.24 million -15.1%4.5%2 $1.72 10/29/2021849,800 shares $1.51 million -21.3%5.6%2.2 $1.78Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 10/15/20211,080,000 shares $2.46 million +6.9%6.9%1.6 $2.28 9/30/20211,010,000 shares $2.08 million -18.6%6.5%1.6 $2.06 9/15/20211,240,000 shares $2.26 million -0.8%8.0%2.1 $1.82 8/31/20211,250,000 shares $2.45 million -27.3%8.1%1.8 $1.96 8/13/20211,720,000 shares $3.13 million +10.3%11.2%0.6 $1.82 7/30/20211,560,000 shares $2.95 million +1.3%19.8%0.5 $1.89 7/15/20211,540,000 shares $2.82 million -1.9%19.5%0.5 $1.83 6/30/20211,570,000 shares $3.60 million +6.1%19.9%0.5 $2.29 6/15/20211,480,000 shares $3.37 million +108.2%18.8%0.5 $2.28 5/28/2021710,900 shares $1.26 million +10.8%9.0%0.2 $1.77 5/14/2021641,500 shares $1.08 million +95.6%8.1%0.9 $1.68 4/30/2021328,000 shares $734.72 thousand +35.9%4.7%0.7 $2.24 4/15/2021241,400 shares $555.22 thousand +87.1%3.5%0.6 $2.30 3/31/2021129,000 shares $276.06 thousand -18.2%3.9%0.4 $2.14 3/15/2021157,600 shares $660.34 thousand +81.4%4.6%1 $4.19 2/26/202186,900 shares $438.41 thousand +1.6%2.5%1.8 $5.05 2/12/202185,500 shares $469.40 thousand -3.9%2.5%3.6 $5.49 1/29/202189,000 shares $501.07 thousand -0.8%2.6%5 $5.63 1/15/202189,700 shares $554.35 thousand No Change2.6%6.5 $6.18 WINT Short Interest - Frequently Asked Questions What is Windtree Therapeutics' current short interest? Short interest is the volume of Windtree Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 2,600,000 shares of WINT short. Learn More on Windtree Therapeutics' current short interest. Is Windtree Therapeutics' short interest increasing or decreasing? Windtree Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 2,600,000 shares, an increase of 1,508.9% from the previous total of 161,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Windtree Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Windtree Therapeutics: Ernexa Therapeutics Inc. (1.68%), Bullfrog AI Holdings Inc. (3.97%), AlloVir, Inc. (2.56%), BioVie Inc. (9.49%), Flora Growth Corp. (1.44%), TherapeuticsMD, Inc. (0.16%), Phio Pharmaceuticals Corp. (6.95%), BioCardia, Inc. (4.96%), Sonnet BioTherapeutics Holdings, Inc. (18.42%), GeoVax Labs Inc. (15.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Windtree Therapeutics stock? Short selling WINT is an investing strategy that aims to generate trading profit from Windtree Therapeutics as its price is falling. WINT shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Windtree Therapeutics? A short squeeze for Windtree Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WINT, which in turn drives the price of the stock up even further. How often is Windtree Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WINT, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies ERNA Short Interest BFRG Short Interest ALVR Short Interest BIVI Short Interest FLGC Short Interest TXMD Short Interest PHIO Short Interest BCDA Short Interest SONN Short Interest GOVX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WINT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
